Physician profile
Valentin Almendarez
NPI 1326037615
$215,162.89
in general payments reported to CMS, 2019-2025
15 companies · $22K in 2025
The $22K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $18K · 2021: $53K · 2022: $31K · 2023: $46K · 2024: $721 · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $48K · Consulting Fee: $12K · Travel and Lodging: $5,786 · Food and Beverage: $2,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $48,000.00 |
| Consulting Fee | $12,100.00 |
| Travel and Lodging | $5,786.11 |
| Food and Beverage | $2,706.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $182,692.61 | 2019-2025 | Da Vinci Surgical System |
| Meditrina | $27,100.00 | 2021-2024 | |
| Alliance Partners LLC | $4,623.23 | 2019-2020 | |
| Gynesonics, INC. | $380.58 | 2021-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $208.15 | 2020-2022 | |
| Caldera Medical, INC | $26.40 | 2021 | |
| Allergan, INC. | $20.99 | 2020 | |
| Exeltis, USA INC. | $20.58 | 2024 | Slynd |
| Acessa Health INC. | $17.89 | 2019 | |
| Boston Scientific Corporation | $17.50 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $17.27 | 2021 | |
| Pfizer INC. | $16.05 | 2021 | |
| Covidien Lp | $14.17 | 2019 | |
| Allotrope Medical, INC | $7.47 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valentin Almendarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.